Key financial metrics and fundamentals for Taysha Gene Therapies, Inc. (TSHA).
Market Cap
$1.66B
P/E Ratio
-19.48
Forward P/E
--
EPS
$-0.34
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High